Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T11648 |
INCB 3284
|
CCR | Immunology/Inflammation; Microbiology/Virology |
INCB 3284 是一种可口服且具有选择性和高亲和力的趋化因子受体 2 (CCR2) 拮抗剂,抑制单核细胞趋化蛋白 1 与 hCCR2 相互作用。INCB 3284 可用于研究失血性休克。 | |||
T11647 |
INCB 3284 dimesylate
|
Others | Others |
INCB 3284 dimesylate is a selective and orally bioavailable human CCR2 antagonist, inhibiting monocyte chemoattractant protein-1 binding to hCCR2 (IC50: 3.7 nM). It can be used in the research of acute liver failure. |